Table 3.
Characteristics of the 23 K. pneumoniae isolates
| Isolate | Ward | PFGE cluster/group | ESBL type | Antibiotic resistance other than β-Lactams | Incompatibility group |
|---|---|---|---|---|---|
| 20 | A | B1 | CTX-M-3, TEM-1 | GM, TET, SXT, CIP | FIA, FIB |
| 61 | G | B1 | TEM-104 | GM, TET, SXT, CIP | FII, FIA, FIB |
| 25 | I | B2 | TEM-54 | GM, TET, SXT, CIP | FII, FIA, FIB |
| 57 | C | B2 | CTX-M-15, TEM-1 | GM, TET | FIA |
| 76 | B | B3 | CTX-M-15, TEM-1 | GM, TET, SXT, CIP | FIA, FIB |
| 82 | B | B3 | CTX-M-15, TEM-1 | GM, TET, SXT, CIP | FIA, FIB |
| 84 | B | B3 | CTX-M-15, TEM-1 | GM, TET, SXT, CIP | FIA, FIB |
| 115 | A | B3 | CTX-M-15, TEM-1 | GM, TET, SXT, CIP | FIA |
| 116 | A | B3 | CTX-M-15, TEM-1 | GM, TET, SXT, CIP | FIA, FIB |
| 30 | B | B3 | CTX-M-15, TEM-1 | GM, TET, SXT, CIP | FIA, FIB |
| 33 | A | B3 | CTX-M-15, TEM-1 | GM, TET, SXT, CIP | FIA, FIB |
| 34 | I | B3 | CTX-M-15, TEM-1 | GM, TET, SXT, CIP | FIA, FIB |
| 39 | B | B3 | CTX-M-15, TEM-1 | GM, TET, SXT, CIP | FIA, FIB |
| 31 | C | B3 | CTX-M-15, TEM-1 | GM, TET, SXT, CIP | FIA, FIB |
| 46 | B | B3 | CTX-M-15, TEM-1 | GM, TET, SXT, CIP | FIA, FIB |
| 65 | B | B3 | CTX-M-15, TEM-1 | GM, TET, SXT, CIP | FIA, FIB |
| *71 | B | B3 | TEM-1 | GM, TET, SXT, CIP | FIA, FIB |
| 78 | B | B3 | CTX-M-15, TEM-1 | GM, TET, SXT, CIP | FIA, FIB |
| 96 | G | B3 | CTX-M-15, TEM-1 | GM, TET, SXT, CIP | FIA, FIB |
| 80 | A | B3 | CTX-M-15, TEM-1 | GM, TET, SXT, CIP | FIA, FIB |
| 89 | C | B3 | CTX-M-3, TEM-1 | GM, TET, SXT, CIP | FIA, FIB |
| 5 | C | B3 | TEM-104 | GM, TET, SXT, CIP | ND |
| 52 | A | B3 | CTX-M-3, TEM-1 | GM, SXT, CIP | FIA, FIB |
*This isolate was positive for ESBL phenotypically but no ESBL gene was found
GM: Gentamicin, TET: Tetracycline, CIP: Ciprofloxacin, SXT: Sulphamethaxazole/trimethoprim, ND: not determined